In the 2005 and 2006 report cards, we analyzed the access to the 24 new cancer drugs, province by province. When we came to Quebec, it was very difficult to determine the true access, because although the provincial government will approve a drug, not every hospital is given the money to use the drug. So there's intra-hospital variation in access to the drugs. For the some of the drugs, if you go to hospital A, you'll get them, and if you go to hospital B, you won't get them, even though the province has approved the use of the drug throughout the province. We don't have the resources to drill down on just how much of that is—
On April 30th, 2007. See this statement in context.